-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 7, China Resources Double-Crane issued an announcement stating that the subsidiary had received the Nifedipine Sustained-Release Tablets (II) "Drug Supplementary Application Approval Notice" approved and issued by the State Food and Drug Administration.
The drug mainly treats chronic stable angina pectoris (worked angina pectoris), vasospasm angina pectoris (Prinzmetal's angina pectoris, variant angina pectoris) and essential hypertension.
As of the date of this announcement, Shuanghe Limin has invested RMB 8.